Literature DB >> 23640892

Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

Allison M Land1, Emily K Law, Michael A Carpenter, Lela Lackey, William L Brown, Reuben S Harris.   

Abstract

APOBEC3A (A3A) is a myeloid lineage-specific DNA cytosine deaminase with a role in innate immunity to foreign DNA. Previous studies have shown that heterologously expressed A3A is genotoxic, suggesting that monocytes may have a mechanism to regulate this enzyme. Indeed, we observed no significant cytotoxicity when interferon was used to induce the expression of endogenous A3A in CD14(+)-enriched primary cells or the monocytic cell line THP-1. In contrast, doxycycline-induced A3A in HEK293 cells caused major cytotoxicity at protein levels lower than those observed when CD14(+) cells were stimulated with interferon. Immunofluorescent microscopy of interferon-stimulated CD14(+) and THP-1 cells revealed that endogenous A3A is cytoplasmic, in stark contrast to stably or transiently transfected A3A, which has a cell-wide localization. A3A constructs engineered to be cytoplasmic are also nontoxic in HEK293 cells. These data combine to suggest that monocytic cells use a cytoplasmic retention mechanism to control A3A and avert genotoxicity during innate immune responses.

Entities:  

Keywords:  APOBEC3A; Cytoplasmic Localization; DNA Cytosine Deamination; DNA Damage; Gamma-H2AX; Genotoxicity; HIV; Innate Immunity; Interferon; Monocytes

Mesh:

Substances:

Year:  2013        PMID: 23640892      PMCID: PMC3682529          DOI: 10.1074/jbc.M113.458661

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  APOBEC3 proteins inhibit human LINE-1 retrotransposition.

Authors:  Heide Muckenfuss; Matthias Hamdorf; Ulrike Held; Mario Perkovic; Johannes Löwer; Klaus Cichutek; Egbert Flory; Gerald G Schumann; Carsten Münk
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

2.  Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.

Authors:  Gang Peng; Teresa Greenwell-Wild; Salvador Nares; Wenwen Jin; Ke Jian Lei; Zoila G Rangel; Peter J Munson; Sharon M Wahl
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

3.  APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot traffic.

Authors:  Ryan P Bennett; Elie Diner; Mark P Sowden; Joshua A Lees; Joseph E Wedekind; Harold C Smith
Journal:  Biochem Biophys Res Commun       Date:  2006-09-18       Impact factor: 3.575

4.  High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.

Authors:  Ya-Lin Chiu; H Ewa Witkowska; Steven C Hall; Mario Santiago; Vanessa B Soros; Cécile Esnault; Thierry Heidmann; Warner C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.

Authors:  Anna Maria Niewiadomska; Chunjuan Tian; Lindi Tan; Tao Wang; Phuong Thi Nguyen Sarkis; Xiao-Fang Yu
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

7.  Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.

Authors:  Sarah Gallois-Montbrun; Beatrice Kramer; Chad M Swanson; Helen Byers; Steven Lynham; Malcolm Ward; Michael H Malim
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

8.  APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

Authors:  Gregory Berger; Stéphanie Durand; Guillaume Fargier; Xuan-Nhi Nguyen; Stéphanie Cordeil; Serge Bouaziz; Delphine Muriaux; Jean-Luc Darlix; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

9.  All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition.

Authors:  Masanobu Kinomoto; Takayuki Kanno; Mari Shimura; Yukihito Ishizaka; Asato Kojima; Takeshi Kurata; Tetsutaro Sata; Kenzo Tokunaga
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

10.  Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.

Authors:  Ritu Goila-Gaur; Mohammad A Khan; Eri Miyagi; Sandra Kao; Klaus Strebel
Journal:  Retrovirology       Date:  2007-08-29       Impact factor: 4.602

View more
  40 in total

1.  APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.

Authors:  Daniel J Salamango; Jordan T Becker; Jennifer L McCann; Adam Z Cheng; Özlem Demir; Rommie E Amaro; William L Brown; Nadine M Shaban; Reuben S Harris
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

Review 2.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

3.  Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain.

Authors:  Miki Katuwal; Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Kalani Halemano; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2014-09-28       Impact factor: 3.616

4.  Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.

Authors:  In-Ja L Byeon; Chang-Hyeock Byeon; Tiyun Wu; Mithun Mitra; Dustin Singer; Judith G Levin; Angela M Gronenborn
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

Review 5.  Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.

Authors:  Sachini U Siriwardena; Kang Chen; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2016-09-01       Impact factor: 60.622

6.  APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.

Authors:  Rémi Buisson; Michael S Lawrence; Cyril H Benes; Lee Zou
Journal:  Cancer Res       Date:  2017-07-11       Impact factor: 12.701

7.  Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.

Authors:  Candace D Middlebrooks; A Rouf Banday; Konichi Matsuda; Krizia-Ivana Udquim; Olusegun O Onabajo; Ashley Paquin; Jonine D Figueroa; Bin Zhu; Stella Koutros; Michiaki Kubo; Taro Shuin; Neal D Freedman; Manolis Kogevinas; Nuria Malats; Stephen J Chanock; Montserrat Garcia-Closas; Debra T Silverman; Nathaniel Rothman; Ludmila Prokunina-Olsson
Journal:  Nat Genet       Date:  2016-09-19       Impact factor: 38.330

8.  Evidence for APOBEC3B mutagenesis in multiple human cancers.

Authors:  Michael B Burns; Nuri A Temiz; Reuben S Harris
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

9.  The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.

Authors:  Artur A Serebrenik; Prokopios P Argyris; Matthew C Jarvis; William L Brown; Martina Bazzaro; Rachel I Vogel; Britt K Erickson; Sun-Hee Lee; Krista M Goergen; Matthew J Maurer; Ethan P Heinzen; Ann L Oberg; Yajue Huang; Xiaonan Hou; S John Weroha; Scott H Kaufmann; Reuben S Harris
Journal:  Clin Cancer Res       Date:  2020-02-14       Impact factor: 12.531

10.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.